Food & Drink / Compounds / Saccharin

Saccharin in food: ingestion safety

Low risk

Dietary ingestion via diet beverages, tabletop sweeteners (Sweet'N Low), medications, and processed foods is the primary saccharin exposure route. A key practical distinction is between saccharin and newer sweeteners: saccharin has a characteristic metallic aftertaste at high concentrations, which has reduced its market share in favor of aspartame (hq-c-org-000042), acesulfame-K, sucralose, and stevia-derived sweeteners. Saccharin remains widely used in medications and dental products due to its heat stability and chemical inertness. ADI-compliant dietary saccharin exposure is definitively non-carcinogenic in humans. An emerging area of concern is gut microbiome disruption — a 2022 study published in Cell demonstrated that saccharin altered gut microbiome composition in some human participants in a way associated with dysglycemia, raising new questions about non-carcinogenic metabolic effects. This does not change the risk_level assessment at current dietary levels but is a notable development in saccharin research.

What is saccharin?

The IUPAC name is 1,1-dioxo-1,2-benzothiazol-3-one.

Also known as: 1,1-dioxo-1,2-benzothiazol-3-one, o-Benzoic sulfimide, o-Sulfobenzimide, Saccharine.

IUPAC name
1,1-dioxo-1,2-benzothiazol-3-one
CAS number
81-07-2
Molecular formula
C7H5NO3S
Molecular weight
183.19 g/mol
SMILES
C1=CC=C2C(=C1)C(=O)NS2(=O)=O
PubChem CID
5143

Risk for people

Low risk

Dietary ingestion via diet beverages, tabletop sweeteners (Sweet'N Low), medications, and processed foods is the primary saccharin exposure route. A key practical distinction is between saccharin and newer sweeteners: saccharin has a characteristic metallic aftertaste at high concentrations, which has reduced its market share in favor of aspartame (hq-c-org-000042), acesulfame-K, sucralose, and stevia-derived sweeteners. Saccharin remains widely used in medications and dental products due to its heat stability and chemical inertness. ADI-compliant dietary saccharin exposure is definitively non-carcinogenic in humans. An emerging area of concern is gut microbiome disruption — a 2022 study published in Cell demonstrated that saccharin altered gut microbiome composition in some human participants in a way associated with dysglycemia, raising new questions about non-carcinogenic metabolic effects. This does not change the risk_level assessment at current dietary levels but is a notable development in saccharin research.

Regulatory consensus

8 regulatory and scientific bodies have classified Saccharin. The classifications differ — that's the data.

AgencyYearClassificationNotes
EPA CTX / IARC—Group 3 - Not classifiable as to its carcinogenicity to humans
EPA CTX / CalEPA—Known human carcinogen
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 8 positive / 13 negative reports)
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 8 positive / 13 negative reports)
EPA CTX / Skin-Eye—skin sensitisation: in vivo (LLNA): Not likely to be sensitizing (score: low)
EPA CTX / Skin-Eye—skin sensitisation: Not likely to be sensitizing (score: low)
EPA CTX / Skin-Eye—eye irritation: in vivo: Studies Indicate No Significant Irritation (score: low)
EPA CTX / Skin-Eye—skin irritation: in vivo: Studies Indicate No Significant Irritation (score: low)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where you encounter saccharin

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles
  • Food — processed food, beverages, candy, baked goods

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Saccharin:

  • Fragrance-free formulations
    Trade-offs: Consumer preference for scented products
    Relative cost: Lower (ingredient elimination)
  • Essential oil-based fragrances (with disclosure)
    Trade-offs: Natural does not mean safe — many essential oils are skin sensitizers
    Relative cost: 2-5× conventional

Frequently asked questions

Is saccharin safe for you?

Dietary ingestion via diet beverages, tabletop sweeteners (Sweet'N Low), medications, and processed foods is the primary saccharin exposure route. A key practical distinction is between saccharin and newer sweeteners: saccharin has a characteristic metallic aftertaste at high concentrations, which has reduced its market share in favor of aspartame (hq-c-org-000042), acesulfame-K, sucralose, and stevia-derived sweeteners. Saccharin remains widely used in medications and dental products due to its heat stability and chemical inertness. ADI-compliant dietary saccharin exposure is definitively non-carcinogenic in humans. An emerging area of concern is gut microbiome disruption — a 2022 study published in Cell demonstrated that saccharin altered gut microbiome composition in some human participants in a way associated with dysglycemia, raising new questions about non-carcinogenic metabolic effects. This does not change the risk_level assessment at current dietary levels but is a notable development in saccharin research.

What products contain saccharin?

Saccharin appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments); processed food (Food).

Why do regulators disagree about saccharin?

Saccharin has been classified by 8 agencies including EPA CTX / IARC, EPA CTX / CalEPA, EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Saccharin in the food app

Look up products containing saccharin, compare to alternatives, and explore the full data record.

Open in food View raw API data

Sources (4)
  1. US FDA: Saccharin — GRAS Affirmation (2010), History of Proposed Bans, NTP Delisting (2000), ADI 5 mg/kg bw/day, and Current Regulatory Status in US Food Supply (2022) (2022) — regulatory
  2. IARC Monographs Supplement 7 (1987): Saccharin — Reclassification to Group 4 (Probably Not Carcinogenic to Humans); Male Rat-Specific Alpha-2u-Globulin Bladder Tumor Mechanism; Species Specificity Not Applicable to Humans (1987) — academic
  3. US National Toxicology Program: Saccharin Removal from Report on Carcinogens (2000) — Rat Bladder Mechanism Human Non-Relevance, Extensive Human Epidemiology Data, and Prop 65 Delisting (2001) (2000) — regulatory
  4. EFSA Panel on Food Additives: Re-evaluation of Saccharin and Its Sodium, Potassium and Calcium Salts (E954) — ADI 5 mg/kg bw/day Confirmation, Safety for Children, and Dietary Exposure Assessment (EFSA Journal 2012;10(6):2728) (2012) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →